Skip to content

Clinical Observation of Shegan Mixture

The process and quality standards improvement of Shegan Mixture and it's clinical evaluation

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPC-15007276
Enrollment
Unknown
Registered
2015-10-25
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Upper respiratory tract infection, Tracheobronchitis

Interventions

Experience group:Basic therapy+Shegan Mixture
Chinese medicine control group:Basic therapy+Xuanfeizhisou Mixture
Western medicine control group:Basic therapy+Ambroxol

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adult Part: 1. People was diagnosed as Cough by TCM and its Syndromes belong to wind-heat invading lung, dryness evil invading the lung, Phlegm heat obstructing lung; 2. People was diagnosed as Acute upper respiratory tract infection, Acute bronchitis or Acute exacerbation of chronic bronchitis; 3. The Participants are between 18~70 years old, male or female who can complete the treatment and interview. 4. The Participants are required to sign the Informed Consent. Children Part 1. People was diagnosed as Cough by TCM and its Syndromes belong to wind-heat invading lung, dryness evil invading the lung, Phlegm heat obstructing lung; 2. People was diagnosed as Acute upper respiratory tract infection, Acute bronchitis; 3. The Participants are under 18 years old, male or female who can complete the treatment and interview. 4. The Participants are required to sign the Informed Consent.

Exclusion criteria

Exclusion criteria: 1. The cough caused by other Syndromes or disease diagnosed by TCM will be excluded; 2. The cough caused by other disease will be excluded; 3. People with serious complication will be excluded 4. People with other serious disease which unsuitable for this trial will be excluded 5. People allergic to the drug will be excluded 6. People who joined other trial within 3 months will be exclude. 7. People who do not agree with the treatment will be excluded. 8. Pregnancy or breast-feeding women will be excluded.

Design outcomes

Primary

MeasureTime frame
Cough symptom score;TCM symptom score;Cough visual analog scale;

Countries

China

Contacts

Public ContactWU Min
xinhuayiyuan123@126.com+86 13601884805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026